JP2006502235A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502235A5
JP2006502235A5 JP2004568899A JP2004568899A JP2006502235A5 JP 2006502235 A5 JP2006502235 A5 JP 2006502235A5 JP 2004568899 A JP2004568899 A JP 2004568899A JP 2004568899 A JP2004568899 A JP 2004568899A JP 2006502235 A5 JP2006502235 A5 JP 2006502235A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
amino
heteroaryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004568899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502235A (ja
JP4518956B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2003/003823 external-priority patent/WO2004026863A1/en
Publication of JP2006502235A publication Critical patent/JP2006502235A/ja
Publication of JP2006502235A5 publication Critical patent/JP2006502235A5/ja
Application granted granted Critical
Publication of JP4518956B2 publication Critical patent/JP4518956B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004568899A 2002-09-18 2003-09-08 トランスフォーミング成長因子(tgf)阻害剤としての新規トリアゾールおよびオキサゾール化合物 Expired - Fee Related JP4518956B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41212002P 2002-09-18 2002-09-18
US47126503P 2003-05-16 2003-05-16
US48458103P 2003-07-02 2003-07-02
PCT/IB2003/003823 WO2004026863A1 (en) 2002-09-18 2003-09-08 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors

Publications (3)

Publication Number Publication Date
JP2006502235A JP2006502235A (ja) 2006-01-19
JP2006502235A5 true JP2006502235A5 (OSRAM) 2006-09-28
JP4518956B2 JP4518956B2 (ja) 2010-08-04

Family

ID=32034216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004568899A Expired - Fee Related JP4518956B2 (ja) 2002-09-18 2003-09-08 トランスフォーミング成長因子(tgf)阻害剤としての新規トリアゾールおよびオキサゾール化合物

Country Status (28)

Country Link
US (1) US7273936B2 (OSRAM)
EP (1) EP1542994B1 (OSRAM)
JP (1) JP4518956B2 (OSRAM)
KR (1) KR20050057415A (OSRAM)
CN (1) CN1681810A (OSRAM)
AP (1) AP2005003261A0 (OSRAM)
AR (1) AR041273A1 (OSRAM)
AT (1) ATE430147T1 (OSRAM)
AU (1) AU2003256003A1 (OSRAM)
BR (1) BR0314383A (OSRAM)
CA (1) CA2499429C (OSRAM)
CO (1) CO5550473A2 (OSRAM)
CR (1) CR7743A (OSRAM)
DE (1) DE60327443D1 (OSRAM)
EA (1) EA200500354A1 (OSRAM)
ES (1) ES2323421T3 (OSRAM)
HR (1) HRP20050250A2 (OSRAM)
IS (1) IS7711A (OSRAM)
MA (1) MA27443A1 (OSRAM)
MX (1) MXPA05002332A (OSRAM)
NO (1) NO20051838L (OSRAM)
OA (1) OA12926A (OSRAM)
PA (1) PA8582701A1 (OSRAM)
PE (1) PE20040987A1 (OSRAM)
PL (1) PL375975A1 (OSRAM)
TW (1) TW200413362A (OSRAM)
UY (1) UY27978A1 (OSRAM)
WO (1) WO2004026863A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039241A1 (es) * 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
UA80295C2 (en) * 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
EA200500377A1 (ru) * 2002-09-18 2005-08-25 Пфайзер Продактс Инк. Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
AU2003263404A1 (en) 2002-09-18 2004-04-08 Pfizer Products Inc. Novel imidazole compounds as transforming growth factor (tgf) inhibitors
PA8595001A1 (es) * 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
GB0313914D0 (en) * 2003-06-16 2003-07-23 Smithkline Beecham Corp Compounds
SG155222A1 (en) * 2004-08-13 2009-09-30 Genentech Inc Thiazole based inhibitors of atp-utilizing enzymes
US20070275968A1 (en) * 2004-09-07 2007-11-29 Hitoshi Kurata Substituted Biphenyl Derivative
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003319A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580855A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2007070866A2 (en) * 2005-12-16 2007-06-21 Alcon, Inc. Control of intraocular pressure using alk5 modulation agents
WO2008150827A1 (en) * 2007-05-29 2008-12-11 Smithkline Beecham Corporation Naphthyridine, derivatives as p13 kinase inhibitors
WO2009111502A2 (en) 2008-03-03 2009-09-11 University Of Notre Dame Du Lac Anti-cancer compounds, synthesis thereof, and methods of using same
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
AU2012203026B2 (en) * 2008-03-21 2014-06-12 Novartis Ag Novel heterocyclic compounds and uses thereof
EP2300466B1 (en) 2008-06-20 2014-08-06 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
US9242969B2 (en) 2013-03-14 2016-01-26 Novartis Ag Biaryl amide compounds as kinase inhibitors
WO2015103355A1 (en) 2014-01-01 2015-07-09 Medivation Technologies, Inc. Compounds and methods of use
UY36294A (es) 2014-09-12 2016-04-29 Novartis Ag Compuestos y composiciones como inhibidores de quinasa
CN105585565B (zh) * 2014-10-23 2019-10-01 中国医学科学院药物研究所 含2-苯胺基-4-噻唑基吡啶衍生物及其制法和药物组合物与用途
CN106243012A (zh) * 2016-08-02 2016-12-21 北方民族大学 新型吲哚类衍生物及其制备方法
KR102341660B1 (ko) 2016-09-19 2021-12-23 노파르티스 아게 Raf 억제제 및 erk 억제제를 포함하는 치료적 조합
CN110494166B (zh) 2017-05-02 2022-11-08 诺华股份有限公司 组合疗法
IL271149B2 (en) * 2017-06-14 2024-05-01 Trevena Inc Compounds for modulating s1p1 activity and methods of using the same
BR112021022335A2 (pt) 2019-05-13 2021-12-28 Novartis Ag Formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinopiridin-4-il)-4-metilfenil)-2 (trifluorome-til)isonicotinamida como inibidores raf para o tratamento de câncer
CN112694477B (zh) * 2019-10-22 2024-02-06 四川科伦博泰生物医药股份有限公司 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途
JP2023502123A (ja) 2019-11-19 2023-01-20 トレベナ・インコーポレイテッド S1p1モジュレーター化合物及び化合物を調製する方法
CN115466260B (zh) * 2022-09-06 2023-10-13 延边大学 含氨基酸结构的咪唑和噻唑类衍生物及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3486009T2 (de) 1983-09-09 1993-04-15 Takeda Chemical Industries Ltd 5-pyridyl-1,3-thiazol-derivate, ihre herstellung und anwendung.
GB9201692D0 (en) 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US6514977B1 (en) 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors
CA2288787A1 (en) 1997-05-22 1998-11-26 G.D. Searle And Co. Pyrazole derivatives as p38 kinase inhibitors
EP0983260A2 (en) 1997-05-22 2000-03-08 G.D. Searle & Co. 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
JPH11193281A (ja) 1997-10-27 1999-07-21 Takeda Chem Ind Ltd アデノシンa3受容体拮抗剤およびチアゾール化合物
DE60001229T2 (de) * 1999-04-09 2003-10-30 Smithkline Beecham Corp., Philadelphia Triarylimidazole
EP1205478A4 (en) 1999-08-06 2004-06-30 Takeda Chemical Industries Ltd P38MAP KINASE INHIBITORS
CO5271680A1 (es) 2000-02-21 2003-04-30 Smithkline Beecham Corp Compuestos
GB0007405D0 (en) 2000-03-27 2000-05-17 Smithkline Beecham Corp Compounds
PE20020506A1 (es) 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
GB0027987D0 (en) * 2000-11-16 2001-01-03 Smithkline Beecham Plc Compounds
EP1349851A4 (en) 2000-11-16 2004-09-08 Smithkline Beecham Corp COMPOUNDS
EP1354603A1 (en) 2000-12-26 2003-10-22 Takeda Chemical Industries, Ltd. Concomitant drugs
GB0100762D0 (en) 2001-01-11 2001-02-21 Smithkline Beecham Plc Novel use
EP1363904A1 (en) 2001-02-02 2003-11-26 Glaxo Group Limited Pyrazoles as tgf inhibitors
GB0102665D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
WO2002066462A1 (en) 2001-02-02 2002-08-29 Glaxo Group Limited Pyrazole derivatives against tgf overexpression
GB0102672D0 (en) 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
GB0102673D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
EP1357116A4 (en) 2001-02-02 2005-06-01 Yamanouchi Pharma Co Ltd 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF
GB0102668D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
CA2450400A1 (en) 2001-06-11 2002-12-19 Takeda Chemical Industries, Ltd. Medicinal compositions
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
AR040726A1 (es) 2002-07-31 2005-04-20 Smithkline Beecham Corp Compuesto de 2- fenilpiridin-4-il-heterociclico, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
GB0217787D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd C ompounds
AU2003260810A1 (en) 2002-09-18 2004-04-08 Pfizer Products Inc. Triazole derivatives as transforming growth factor (tgf) inhibitors
PL375973A1 (en) 2002-09-18 2005-12-12 Pfizer Products Inc. Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors
AU2003263404A1 (en) 2002-09-18 2004-04-08 Pfizer Products Inc. Novel imidazole compounds as transforming growth factor (tgf) inhibitors
EA200500377A1 (ru) 2002-09-18 2005-08-25 Пфайзер Продактс Инк. Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)

Similar Documents

Publication Publication Date Title
JP2006502235A5 (OSRAM)
JP2006506443A5 (OSRAM)
CA2499429A1 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
RU2348627C2 (ru) Ингибиторы тирозинкиназ
RU2401658C2 (ru) Гетероциклические ингибиторы аспартилпротеазы
IL278297B1 (en) Transmutable heterocyclic ptpn11 inhibitors
JP2010031025A5 (OSRAM)
CA2496295A1 (en) Novels pyrazole compounds as transforming growth factor (tgf) inhibitors
JP2011509949A5 (OSRAM)
JP2008535902A5 (OSRAM)
JP2007516206A5 (OSRAM)
JP2009538897A5 (OSRAM)
JP2008535903A5 (OSRAM)
JP2004528334A5 (OSRAM)
CY1113538T1 (el) Παραγωγα της 5-αμινο-2,4,7-τριοξο-3,4,7,8-τετραϋδρο-2η-πυριδο[2,3-d] πυριμιδινης και παρομοιες ενωσεις για την αγωγη του καρκινου
JP2011219498A5 (OSRAM)
PE20130385A1 (es) Derivados del acido naft-2-ilacetico para tratar el sida
RU2004130488A (ru) Пиримидиновые производные
JP2007511535A5 (OSRAM)
JP2009526830A5 (OSRAM)
CA2475434A1 (en) Aromatic amino acid derivatives and medicinal compositions
JP2010513322A5 (OSRAM)
RU2013130256A (ru) Новые циклоспориновые производные для лечения и предупреждения вирусных инфекций
US11001581B2 (en) Compounds which inhibit RNA polymerase, compositions including such compounds, and their use
JP2006501201A5 (OSRAM)